A new treatment for a condition that can feel like tiny people skating on razor blades in your stomach and affects an estimated 200 million women just got approved (ABBV)

Doctors surgery uterine fibroidsReuters

  • The FDA just approved elagolix, a new treatment for women living with endometriosis.
  • Endometriosis, a condition that affects millions of women, occurs when tissue from the uterus grows outside of it, leading to cysts, heavy bleeding, and scarring. 
  • It’s the first new treatment in a pill form for the disorder in more than a decade. 

The FDA just approved a new treatment for endometriosis. 

The drug, elagolix — now marketed as Orilissa — is made by AbbVie in partnership with Neurocrine Biosciences, and it’s taken as a daily pill.  
It’s the first new treatment for the disorder in a pill form in more than a decade. 

See the rest of the story at Business Insider

NOW WATCH: A Nobel Prize-winning economist says ‘non-competes’ are keeping wages down for all workers

See Also:

SEE ALSO: ‘Nobody’s talking about’ 2 medical conditions that affect 8 million women in America — but that could be about to change

DON’T MISS: A woman who’s worked in venture capital for 25 years shares her best career advice — and why it was worth being the first and only woman on her team when she started out

Post Author: martin

Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now. He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.